Group One Trading
QNTM

Group One Trading’s Quantum Biopharma Class B Subordinate Voting Shares QNTM Stock Holding History

Group One Trading’s Portfolio QNTM Stock Details QNTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$164 Hold
34
– – ﹤0.01% 7404
2025
Q4 		$248 Hold
34
– – ﹤0.01% 7869
2025
Q3 		$558 Hold
34
– – ﹤0.01% 8133
2025
Q2 		$688 Sell
34
-81
-70% -$999 ﹤0.01% 7623
2025
Q1 		$887 Sell
115
-18
-14% -$103 ﹤0.01% 7198
2024
Q4 		$489 Sell
133
-39
-23% -$184 ﹤0.01% 7003
2024
Q3 		$688 Sell
172
-26
-13% -$162 ﹤0.01% 6351
2024
Q2 		$2.06K Sell
198
-74
-27% -$1.8K ﹤0.01% 6218
2024
Q1 		$12.6K Hold
272
– – ﹤0.01% 5731
2023
Q4 		$16.2K Sell
272
-10
-4% -$704 ﹤0.01% 5902
2023
Q3 		$22.2K Buy
+282
New +$23K ﹤0.01% 5810
2023
Q2 		– Sell
-287
Closed -$24.6K – 8300
2023
Q1 		$28.9K Buy
287
+121
+73% +$10.4K ﹤0.01% 5273
2022
Q4 		$8.51K Sell
166
-11
-6% -$609 ﹤0.01% 6085
2022
Q3 		$10K Sell
177
-270
-60% -$15.9K ﹤0.01% 6521
2022
Q2 		$23K Buy
447
+104
+30% +$6.24K ﹤0.01% 6199
2022
Q1 		$19K Sell
343
-60
-15% -$3.63K ﹤0.01% 6793
2021
Q4 		$27K Buy
403
+136
+51% +$11.8K ﹤0.01% 6790
2021
Q3 		$27K Buy
+267
New +$28.5K ﹤0.01% 7000

Other funds holding QNTM

AI
AdvisorShares Investments Bethesda, Maryland $549M AUM 32.58% 1-Year Est. Return
PTP
Platform Technology Partners New York $611M AUM 25.5% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
MG
Marex Group London $15.8B AUM 31.44% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Mariner
Mariner Overland Park, Kansas $85.7B AUM 24.21% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

Group One Trading's QNTM Position: Q1 2026 in Review

Group One Trading held its Quantum Biopharma Class B Subordinate Voting Shares (QNTM) position steady in Q1 2026 at 34 shares worth $164. The position accounts for ﹤0.01% of the portfolio, ranked #7404.

Group One Trading first reported a position in QNTM in Q3 2021 and has held it in 18 quarters since. The position peaked at $28.9K in Q1 2023. 25 funds tracked by Wall St. Rank hold QNTM as of Q1 2026.

  • Group One Trading held 34 shares of Quantum Biopharma Class B Subordinate Voting Shares worth $164 as of Q1 2026.
  • Group One Trading left its Quantum Biopharma Class B Subordinate Voting Shares share count unchanged in Q1 2026.
  • Quantum Biopharma Class B Subordinate Voting Shares made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #7404 holding.
  • Group One Trading first reported a position in Quantum Biopharma Class B Subordinate Voting Shares in Q3 2021 and has held it in 18 quarters since.
  • Group One Trading's Quantum Biopharma Class B Subordinate Voting Shares position peaked at $28.9K in Q1 2023.
  • 25 funds tracked by Wall St. Rank held Quantum Biopharma Class B Subordinate Voting Shares as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.